BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37001236)

  • 1. Hypothalamic neuroglial plasticity is regulated by anti-Müllerian hormone and disrupted in polycystic ovary syndrome.
    Barbotin AL; Mimouni NEH; Kuchcinski G; Lopes R; Viard R; Rasika S; Mazur D; Silva MSB; Simon V; Boursier A; Pruvo JP; Yu Q; Candlish M; Boehm U; Bello FD; Medana C; Pigny P; Dewailly D; Prevot V; Catteau-Jonard S; Giacobini P
    EBioMedicine; 2023 Apr; 90():104535. PubMed ID: 37001236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood.
    Tata B; Mimouni NEH; Barbotin AL; Malone SA; Loyens A; Pigny P; Dewailly D; Catteau-Jonard S; Sundström-Poromaa I; Piltonen TT; Dal Bello F; Medana C; Prevot V; Clasadonte J; Giacobini P
    Nat Med; 2018 Jun; 24(6):834-846. PubMed ID: 29760445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overactivation of GnRH neurons is sufficient to trigger polycystic ovary syndrome-like traits in female mice.
    Silva MSB; Decoster L; Delpouve G; Lhomme T; Ternier G; Prevot V; Giacobini P
    EBioMedicine; 2023 Nov; 97():104850. PubMed ID: 37898094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in circulating forms of anti-Muüllerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy.
    Peigné M; Simon V; Pigny P; Mimouni NEH; Martin C; Dewailly D; Catteau-Jonard S; Giacobini P
    Hum Reprod; 2023 May; 38(5):938-950. PubMed ID: 36921289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women.
    Bungum L; Franssohn F; Bungum M; Humaidan P; Giwercman A
    PLoS One; 2013; 8(9):e68223. PubMed ID: 24023708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion.
    Cimino I; Casoni F; Liu X; Messina A; Parkash J; Jamin SP; Catteau-Jonard S; Collier F; Baroncini M; Dewailly D; Pigny P; Prescott M; Campbell R; Herbison AE; Prevot V; Giacobini P
    Nat Commun; 2016 Jan; 7():10055. PubMed ID: 26753790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of arcuate nucleus GABA neurons promotes luteinizing hormone secretion and reproductive dysfunction: Implications for polycystic ovary syndrome.
    Silva MSB; Desroziers E; Hessler S; Prescott M; Coyle C; Herbison AE; Campbell RE
    EBioMedicine; 2019 Jun; 44():582-596. PubMed ID: 31178425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
    Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
    Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
    Łebkowska A; Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Milewski R; Górska M; Wołczyński S; Kowalska I
    Metabolism; 2016 May; 65(5):804-811. PubMed ID: 26961579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.
    Zheng MX; Li Y; Hu R; Wang FM; Zhang XM; Guan B
    J Assist Reprod Genet; 2016 Feb; 33(2):199-205. PubMed ID: 26732661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F; Liu XL; Rong N; Huang XW
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of Serum anti-Mullerian hormone responses after recombinant human chorionic gonadotropin stimulation in women with polycystic ovary syndrome.
    Cook-Andersen H; Chuan SS; Maas K; Rosencrantz MA; Su HI; Lawson M; Mason HD; Chang RJ
    J Clin Endocrinol Metab; 2015 Jan; 100(1):251-7. PubMed ID: 25303490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology.
    Hager M; Ott J; Marschalek J; Marschalek ML; Kinsky C; Marculescu R; Dewailly D
    Reprod Biol Endocrinol; 2022 Jul; 20(1):98. PubMed ID: 35787707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-mullerian hormone levels before and after ovarian drilling in polycystic ovary syndrome: has this an effect on fertility?
    Javedani Masroor M; Sheybani H; Sheybani S; Abolghasem N
    Reprod Biol Endocrinol; 2022 Aug; 20(1):129. PubMed ID: 36042475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.